J. Scott Wolchko, President and CEO at FATE THERAPEUTICS INC (FATE), sold 127,999 shares at $114.76 ($14.9M) on 2021-01-08, disclosed to the SEC on 2021-01-12.
Open-market sale of $14.9M FATE by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $114.76 | 1,469 | $169K | 1.1% |
| 2 | $114.76 | 1,469 | $169K | 1.1% |
| 3 | $115.80 | 8,515 | $986K | 6.6% |
| 4 | $117.15 | 23,932 | $2.8M | 18.8% |
| 5 | $117.15 | 23,932 | $2.8M | 18.8% |
| 6 | $117.60 | 26,904 |
| $3.2M |
| 21.2% |
| 7 | $117.60 | 26,904 | $3.2M | 21.2% |
| 8 | $109.65 | 2,300 | $252K | 1.7% |
| 9 | $110.76 | 2,772 | $307K | 2.1% |
| 10 | $110.76 | 2,772 | $307K | 2.1% |
| 11 | $111.62 | 3,515 | $392K | 2.6% |
| 12 | $111.62 | 3,515 | $392K | 2.6% |
| Total | $116.48 avg | 127,999 | $14.9M | 100% |
| Filing → |
| FATE | SELL | 2022-07-25 | $2.4M | — | Filing → |
| FATE | SELL | 2022-04-25 | $2.6M | — | Filing → |
| FATE | SELL | 2022-01-24 | $2.0M | — | Filing → |